Buprenorphine is a potent synthetic opioid-partial antagonist analgesic drug currently under clinical trial. When administered intravenously to human volunteers buprenorphine produced a significant depression of the ventilatory response to carbon dioxide stimulus for a period in excess of six hours.
References
1.
Crampton SmithA., and HahnC. E. W. (1975): “Studies with the ‘Severinghaus’ Pco2 Electrode. I. Electrode Stability, Memory and S Plots”, Brit. J. Anaesth., 47, 553–559.
2.
DrippsR. D., and ComroeJ. H. (1945): “Clinical Studies on Morphine. I. The Immediate Effect of Morphine Administered Intravenously and Intramuscularly on the Respiration of Normal Man”, Anesthesiology, 6, 462–468.
3.
IrsiglerG. B. (1975): “The Carbon Dioxide Response Curve in Normal Adults”, S.A. Med. J., 49, 13–16.
4.
KeatsA. S., and TelfordJ. (1966): “Studies of Analgesic Drugs. X. Respiratory Effects of Narcotic Antagonists”, J. Pharmacol. Exp. Ther., 151, 126–132.
5.
OrwinJ. M., OrwinJ., and PriceM. (1976): “A Double Blind Comparison of Buprenorphine and Morphine in Conscious Subjects Following Administration by the Intramuscular Route”, Acta Anaesthesiologica Belgica (in press).
6.
ReadD. J. C. (1967): “A Clinical Method for Assessing the Ventilatory Response to Carbon Dioxide”, Aust. Ann. Med., 16, 20–32.
